This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
DAREON®-36: A Study to Test Obrixtamig in Combination With ZL-1310 in People With Advanced Small Cell Lung Cancer or Other Neuroendocrine Cancers | MicrobiomeTrials
← Back to trials NCT07707895
DAREON®-36: A Study to Test Obrixtamig in Combination With ZL-1310 in People With Advanced Small Cell Lung Cancer or Other Neuroendocrine Cancers Recruiting PHASE1, PHASE2 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2026-10-28Est. Completion: 2030-04-26
Enrollment target: 60 participantsLocations MedStar Georgetown University Hospital, Washington D.C., District of Columbia, United States H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States University of Kentucky Medical Center, Lexington, Kentucky, United States Chris Obrien Lifehouse, Camperdown, New South Wales, Australia Royal North Shore Hospital, St Leonards, New South Wales, Australia Universitair Ziekenhuis Antwerpen, Edegem, Belgium Universitair Ziekenhuis Gent, Ghent, Belgium The Affiliated Cancer Hospital, Guangxi Medical University, Nanning, China Shanghai Chest Hospital, Shanghai, China Shanghai Pulmonary Hospital, Shanghai, China CTR Leon Berard, Lyon, France HOP Timone, Marseille, France Institut Gustave Roussy, Villejuif, France Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Mainz, Germany Robert Bosch Gesellschaft für medizinische Forschung mbH, Stuttgart, Germany Hokkaido Cancer Center, Hokkaido, Sapporo, Japan St. Marianna University Hospital, Kanagawa, Kawasaki, Japan Other microbiome trials you might be interested in Radiation of Neurocranial Region
This randomized trial examines possible enhancements in live quality and neurocognitive functions in patients after radi…
Erlangen, Germany Est. completion Mar 2024
Non-small Cell Lung Cancer NSCLC
This is a phase 3 study of pembrolizumab in combination with carboplatin/taxane (paclitaxel or nab-paclitaxel) followed …
Little Rock, United States Est. completion Jan 12, 2029
Kansai Medical University Hospital, Osaka, Hirakata, Japan
Shizuoka Cancer Center, Shizuoka, Sunto-gun, Japan
Amsterdam UMC Locatie VUMC, Amsterdam, Netherlands
Szpital Specjalistyczny W Brzozowie Podkarpacki Osrodek Onkologiczny Im.Ks.B.Markiewicza, Brzozów, Poland
Lower Silesian Oncology Centre, Wroclaw, Poland
Hospital Duran i Reynals, L'Hospitalet Del Llobregat, Spain
Hospital Universitario 12 de Octubre, Madrid, Spain
Hospital Clinico De Valencia (INCLIVA), Valencia, Spain
Leicester Royal Infirmary, Leicester, United Kingdom
Freeman Hospital, Newcastle upon Tyne, United Kingdom Phase 3
Recruiting
Lung Non-Small Cell Carcinoma Lung Non-Small Cell Squamous Carcinoma Lung Non-Squamous Non-Small Cell Carcinoma Stage II Lung Cancer AJCC v8 Stage IIIA Lung Cancer AJCC v8 Stage IIIB Lung Cancer AJCC v8
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of …
Anchorage, United States Est. completion Jan 31, 2030